Acuity and case management: a healthy dose of outcomes, part III.

Acuity and case management: a healthy dose of outcomes, part III. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acuity and case management: a healthy dose of outcomes, part III. Abstract Text:

Diane L Huber,Kathy Craig,

PURPOSE OF STUDY: This is the third of a 3-part series presenting 2 effective applications--acuity and dosage--that describe how the business case for case management (CM) can be made. In Part I, dosage and acuity concepts were explained as client need-severity, CM intervention-intensity, and CM activity-dose prescribed by amount, frequency, duration, and breadth of activities. Concepts were presented that related the practice of CM to the use of evidence-based practice (EBP), knowledge, and methods and the development of instruments that measure and score pivotal CM actions. Part I also featured a specific exemplar, the CM Acuity Tool, and described how to use acuity to identify and score the complexity of a CM case. Part II further explained dosage and 2 acuity instruments, the Acuity Tool and AccuDiff. Part III presents linkage to EBP and practical applications. PRIMARY PRACTICE SETTING(S): The information contained in the 3-part series applies to all CM practice settings and contains ideas and recommendations useful to CM generalists, specialists, supervisors, and business and outcomes managers. The Acuity Tools Project was developed from frontline CM practice in one large, national telephonic CM company. METHODOLOGY AND SAMPLE: Dosage: A literature search failed to find research into dosage of a behavioral intervention. The Huber-Hall model was developed and tested in a longitudinal study of CM models in substance abuse treatment and reported in the literature. Acuity: A structured literature search and needs assessment launched the development of the suite of acuity tools. A gap analysis identified that an instrument to assign and measure case acuity specific to CM activities was needed. Clinical experts, quality specialists, and business analysts (n = 7) monitored the development and testing of the tools, acuity concepts, scores, differentials, and their operating principles and evaluated the validity of the acuity tools' content related to CM activities. During the pilot phase of development, interrater reliability testing of draft and final tools for evaluator concordance, b testing for content accuracy and appropriateness, and representative sample size testing were done. Expert panel reviews occurred at multiple junctures along the development pathway, including the 5 critical points after initial tool draft and both before and after b-test (n = 5) and pilot-test (n = 28) evaluations. The pilot testing body (n = 33) consisted of a team of case managers (n = 28) along with quality analysts (n = 2), supervisory personnel (n = 2), and the lead product analyst (the developer). Product evaluation included monitoring weekly reports of open cases for the 28 case managers for 3 months (June-August 2000). RESULTS: The Acuity Tools Suite was used to calculate individual case acuity, overall caseload acuity profiles, case length, and acuity differentials. Normal distributions and outliers were analyzed and the results were used for internal quality improvement and outcomes monitoring. IMPLICATIONS FOR CM PRACTICE: To show value, case managers need to access the evidence base for practice, use tools to capture quantities of intervention intensity, and precisely specify the activities that produce better outcomes. Acuity and dosage can help case managers explore and fully describe their own practice in ways that can be measured, and thus provide data and evidence that contributes to the accumulating body of definitive proof regarding the exceptional worth of CM. Proving business and professional worth in CM through EBP is a clarion call that case managers must heed and an innovation that all case managers can practice.

Acuity and case management: a healthy dose of outcomes, part III. Publishing Authors By Initials

DL Huber,K Craig,

For similar organization and administration: personnel management: workload research abstracts see: organization and administration: personnel management: workload research

PUBMED ID PMID:

MEDLINE DATE:

Acuity and case management: a healthy dose of outcomes, part III. Journal Published:

PUBLICATION TYPE: Validation Studies

Journal: Professional case management

VOLUME: 12

Page Numbers: 254-69; quiz 270-1

Journal Abbreviation:

ISSN: 1932-8087

DAY: 29

MONTH: 11

YEAR: 2007

Acuity and case management: a healthy dose of outcomes, part III. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101291585

Acuity and case management: a healthy dose of outcomes, part III. Keywords Mesh Terms:

KEYWORDS: Workload

MESH TERMS: statistics & numerical data

Chemical & Substance for Abstract: Acuity and case management: a healthy dose of outcomes, part III. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Acuity and case management: a healthy dose of outcomes, part III.

AFFILIATION: Colleges of Nursing and Public Health, University of Iowa, Iowa City, IA 52242, USA. diane-huber@uiowa.edu

Country: United States

AGENCY: United States NIDA

GRANT: DA08733

ACRONYM: DA

MEDLINETA: Prof Case Manag

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acuity and case management: a healthy dose of outcomes, part III Related Publications

• Acuity and case management: a healthy dose of outcomes, part I.
• Acuity and case management: a healthy dose of outcomes, part III.
• Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective?
• Antibiotics for acute pyelonephritis in children.
• Characterization and in vitro cytotoxicity testing of ethanolamine-derived cadmium chelating agents.
• Coincidence of actin filaments and talin is required to activate vinculin.
• Corticosteroid therapy for nephrotic syndrome in children.
• Differential var gene expression in the organs of patients dying of falciparum malaria.
• Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study): cluster randomised trial.
• Exploring the challenges and successes of the Lecturer Practitioner role using a stakeholder evaluation approach.
• Health professionals' perceptions of feeding-related quality of life in children with quadriplegic cerebral palsy.
• Hollow-fibre affinity cell separation.
• How to provide transcutaneous pacing.
• Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies.
• Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
• Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells.
• J-protein co-chaperone Sis1 required for generation of [RNQ+] seeds necessary for prion propagation.
• KRIP6: a novel BTB/kelch protein regulating function of kainate receptors.
• Laser-evoked potentials are graded and somatotopically organized anteroposteriorly in the operculoinsular cortex of anesthetized monkeys.
• N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
• Network of general and specialty J protein chaperones of the yeast cytosol.
• Obsessive-compulsive disorder: boundary issues.
• Physical organic chemistry of supramolecular polymers.
• Prevalence of CYP1B1 mutations in Australian patients with primary congenital glaucoma.
• Retrograde analyses of spinothalamic projections in the macaque monkey: input to ventral posterior nuclei.
• Reversibly cross-linked surface-grafted polymer brushes.
• Strategies for improving pneumococcal vaccination in eligible patients.
• Take charge with an automated external defibrillator.
• The specialized cytosolic J-protein, Jjj1, functions in 60S ribosomal subunit biogenesis.
• [Mixed infection of Echinococcus granulosus and Echinococcus multilocularis in dog]